Cardiometabolic Health Congress

JULY 25, 2024

This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease.

Education 100

Education Innovation Risk Factors Obesity 100

GEMMS

APRIL 3, 2025

As patient expectations rise and technology advances, engaging patients effectively has never been more crucial to delivering top-tier care. GEMMS is committed to enhancing patient care through innovative solutions that improve engagement, streamline workflows, and support cardiovascular care. GEMMS ONE V7.8,

Technology 52

Technology Patient Care Education Innovation 52

Wellnest

DECEMBER 18, 2023

These groundbreaking developments offer a paradigm shift in the management of resistant hypertension, especially when it is extremely difficult to achieve blood pressure control through conventional means, such as lifestyle modifications and various drug therapies. But what is resistant hypertension, and why does it require renal denervation?

Hypertension 52

Hypertension Blood Pressure Reimbursement Ablation 52

Cardiometabolic Health Congress

AUGUST 2, 2024

This innovative approach integrates personal data from multiple biological layers to design bespoke dietary plans, transcending the limitations of one-size-fits-all recommendations. This is particularly beneficial in managing conditions like hypertension, where precise control of dietary sodium intake is crucial.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

DAIC

DECEMBER 19, 2023

This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

APRIL 1, 2024

Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease? Is There Medication for Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

FEBRUARY 7, 2024

milla1cf Wed, 02/07/2024 - 18:05 February 7, 2024 — The Consumer Technology Association ( CTA ) and the American College of Cardiology ( ACC ) are announcing the release of their second industry framework for the use of consumer cardiovascular technology solutions in the screening and diagnosis for cardiovascular conditions.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

FEBRUARY 16, 2024

By expanding our HeartRisk platform, we're not just innovating within traditional healthcare sectors but breaking new ground in diverse markets. The incarcerated population exhibits higher rates of cardiovascular risk factors, such as smoking and hypertension, compared to the general population.

Chronic Disease 91

Chronic Disease Heart Attack Heart attacks Heart Disease 91

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Cardiometabolic Health Congress

AUGUST 8, 2024

We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.

Education 59

Education Cardiovascular Disease Kidney Disease Diabetes 59

DAIC

MAY 21, 2024

The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovascular disease (CVD), the leading cause of death and disability in the United States.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

The Beat Blog

MAY 2, 2023

4 Conditions such as Ischemic Heart Disease, Atrial Fibrillation, Hypertensive Heart Disease, and Ischemic Stroke make up almost 75% of the deaths due to cardiovascular disease. Specialists need to partner with local primary care clinicians – using technology to meet patients where they are – to reverse this reality.

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Technology Hospital 52

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Aprocitentan’s unique mechanism targets endothelin receptors, providing an alternative pathway to lower blood pressure in resistant hypertension cases​.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension.

CMS 52

CMS Blood Pressure Medicare Hypertension 52